173 related articles for article (PubMed ID: 9811046)
1. No increased risk of malignancies and mortality in cyclosporin A-treated patients with rheumatoid arthritis.
van den Borne BE; Landewé RB; Houkes I; Schild F; van der Heyden PC; Hazes JM; Vandenbroucke JP; Zwinderman AH; Goei The HS; Breedveld FC; Bernelot Moens HJ; Kluin PM; Dijkmans BA
Arthritis Rheum; 1998 Nov; 41(11):1930-7. PubMed ID: 9811046
[TBL] [Abstract][Full Text] [Related]
2. The effectiveness and toxicity of cyclosporin A in rheumatoid arthritis: longitudinal analysis of a population-based registry.
Marra CA; Esdaile JM; Guh D; Fisher JH; Chalmers A; Anis AH
Arthritis Rheum; 2001 Jun; 45(3):240-5. PubMed ID: 11409664
[TBL] [Abstract][Full Text] [Related]
3. Mortality in patients with rheumatoid arthritis treated with low-dose oral glucocorticoids. A population-based cohort study.
Sihvonen S; Korpela M; Mustonen J; Huhtala H; Karstila K; Pasternack A
J Rheumatol; 2006 Sep; 33(9):1740-6. PubMed ID: 16881099
[TBL] [Abstract][Full Text] [Related]
4. The risk of hospitalized infection in patients with rheumatoid arthritis.
Smitten AL; Choi HK; Hochberg MC; Suissa S; Simon TA; Testa MA; Chan KA
J Rheumatol; 2008 Mar; 35(3):387-93. PubMed ID: 18260176
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis.
Solomon DH; Avorn J; Katz JN; Weinblatt ME; Setoguchi S; Levin R; Schneeweiss S
Arthritis Rheum; 2006 Dec; 54(12):3790-8. PubMed ID: 17136752
[TBL] [Abstract][Full Text] [Related]
6. Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis.
Lacaille D; Guh DP; Abrahamowicz M; Anis AH; Esdaile JM
Arthritis Rheum; 2008 Aug; 59(8):1074-81. PubMed ID: 18668604
[TBL] [Abstract][Full Text] [Related]
7. Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas.
Geborek P; Bladström A; Turesson C; Gulfe A; Petersson IF; Saxne T; Olsson H; Jacobsson LT
Ann Rheum Dis; 2005 May; 64(5):699-703. PubMed ID: 15695534
[TBL] [Abstract][Full Text] [Related]
8. Treatment of rheumatoid arthritis with total lymphoid irradiation: long-term survival.
Uhrin Z; Wang BW; Matsuda Y; Strober S; Genovese MC
Arthritis Rheum; 2001 Jul; 44(7):1525-8. PubMed ID: 11465702
[TBL] [Abstract][Full Text] [Related]
9. Increased case fatality rates following a first acute cardiovascular event in patients with rheumatoid arthritis.
Van Doornum S; Brand C; King B; Sundararajan V
Arthritis Rheum; 2006 Jul; 54(7):2061-8. PubMed ID: 16802340
[TBL] [Abstract][Full Text] [Related]
10. Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis.
Kremers HM; Nicola PJ; Crowson CS; Ballman KV; Gabriel SE
Arthritis Rheum; 2004 Nov; 50(11):3450-7. PubMed ID: 15529378
[TBL] [Abstract][Full Text] [Related]
11. Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset.
Wållberg-Jonsson S; Johansson H; Ohman ML; Rantapää-Dahlqvist S
J Rheumatol; 1999 Dec; 26(12):2562-71. PubMed ID: 10606363
[TBL] [Abstract][Full Text] [Related]
12. Antirheumatic drug use and the risk of acute myocardial infarction.
Suissa S; Bernatsky S; Hudson M
Arthritis Rheum; 2006 Aug; 55(4):531-6. PubMed ID: 16874796
[TBL] [Abstract][Full Text] [Related]
13. Treatment with TNF blockers and mortality risk in patients with rheumatoid arthritis.
Jacobsson LT; Turesson C; Nilsson JA; Petersson IF; Lindqvist E; Saxne T; Geborek P
Ann Rheum Dis; 2007 May; 66(5):670-5. PubMed ID: 17158824
[TBL] [Abstract][Full Text] [Related]
14. Patients chosen for treatment with cyclosporine because of severe rheumatoid arthritis are more likely to carry HLA-DRB1 shared epitope alleles, and have earlier disease onset.
González-Gay MA; Hajeer AH; García-Porrúa C; Dababneh A; Thomson W; Ollier WE; Mattey DL
J Rheumatol; 2002 Feb; 29(2):271-5. PubMed ID: 11842822
[TBL] [Abstract][Full Text] [Related]
15. Long-term mortality rate in rheumatoid arthritis patients with disease onset in the 1980s.
Kapetanovic MC; Lindqvist E; Geborek P; Saxne T; Eberhard K
Scand J Rheumatol; 2011 Nov; 40(6):433-8. PubMed ID: 21619489
[TBL] [Abstract][Full Text] [Related]
16. Contribution of congestive heart failure and ischemic heart disease to excess mortality in rheumatoid arthritis.
Nicola PJ; Crowson CS; Maradit-Kremers H; Ballman KV; Roger VL; Jacobsen SJ; Gabriel SE
Arthritis Rheum; 2006 Jan; 54(1):60-7. PubMed ID: 16385496
[TBL] [Abstract][Full Text] [Related]
17. Association of the TRAF1/C5 locus with increased mortality, particularly from malignancy or sepsis, in patients with rheumatoid arthritis.
Panoulas VF; Smith JP; Nightingale P; Kitas GD
Arthritis Rheum; 2009 Jan; 60(1):39-46. PubMed ID: 19116907
[TBL] [Abstract][Full Text] [Related]
18. Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with methotrexate.
Buchbinder R; Barber M; Heuzenroeder L; Wluka AE; Giles G; Hall S; Harkness A; Lewis D; Littlejohn G; Miller MH; Ryan PF; Jolley D
Arthritis Rheum; 2008 Jun; 59(6):794-9. PubMed ID: 18512713
[TBL] [Abstract][Full Text] [Related]
19. Do rheumatoid arthritis and lymphoma share risk factors?: a comparison of lymphoma and cancer risks before and after diagnosis of rheumatoid arthritis.
Hellgren K; Smedby KE; Feltelius N; Baecklund E; Askling J
Arthritis Rheum; 2010 May; 62(5):1252-8. PubMed ID: 20155827
[TBL] [Abstract][Full Text] [Related]
20. Dynamic T cell receptor clonotype changes in synovial tissue of patients with early rheumatoid arthritis: effects of treatment with cyclosporin A (Neoral).
VanderBorght A; De Keyser F; Geusens P; De Backer M; Malaise M; Baeten D; Van den Bosch F; Veys EM; Raus J; Stinissen P
J Rheumatol; 2002 Mar; 29(3):416-26. PubMed ID: 11908552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
